Consultant/Senior Consultant at Eli Lilly and Company

Bengaluru, Karnataka, India

Eli Lilly and Company Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Advanced knowledge of health outcomes-related research, including RWE studies, reimbursement dossiers, value message development, economic evaluation, and patient-reported outcome studies
  • Therapeutic area knowledge including disease state, compound, and external environment (including competitors)
  • Ability to provide technical expertise and scientific insights in planning, writing, editing, and reviewing HTA documents while ensuring high-quality standards
  • Skills in document management, including quality checks, collating reviewer comments, adjusting content, and preparing final versions
  • Capability to exhibit flexibility across multiple document types and provide deliverables like reimbursement dossiers or therapy area expertise
  • Experience influencing or negotiating timelines and content with team members
  • Ability to maintain and enhance knowledge, provide informal coaching, share best practices, articulate industry trends, and support cross-functional training
  • Understanding of compliance with internal and external standards and policies
  • Talented, energetic, creative, diverse, influential, and collaborative mindset

Responsibilities

  • Provide technical expertise and share scientific insights while planning, writing, editing, and reviewing HTA documents (40%)
  • Conduct quality checks for data accuracy in documents
  • Collate reviewer’s comments, adjust content based on input, and prepare final versions
  • Provide deliverables (e.g., reimbursement dossier) or therapy area expertise
  • Exhibit flexibility in developing multiple document types and ensure smooth, timely document development
  • Influence or negotiate changes in timelines and content with team members (40% Document Preparation / Management)
  • Maintain and enhance therapeutic area knowledge, including disease state and compound (30% Knowledge and Skills Development)
  • Maintain advanced knowledge of health outcomes research and related areas
  • Lead scientific data disclosure planning, clinical planning, submission strategy, customer regulatory responses, and literature updates/reviews
  • Provide informal coaching, share technical information, give guidance, and answer questions
  • Network to identify and share best practices globally, articulate industry trends, and implement relevant projects/processes
  • Support cross-functional coaching, mentoring, and training (30% Knowledge and Skills Development)
  • Ensure compliance with internal and external standards and policies (25% Operational and Organizational Leadership)
  • Represent Lilly Bengaluru HEOR capability on key cross-functional teams
  • Provide leadership and coaching (25% Operational and Organizational Leadership)

Skills

HEOR
RWE
HTA
Health Economics
Outcomes Research
Real-World Evidence
Project Management
Therapy Area

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI